BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology

  Nine abstracts accepted, including long-term data and subgroup analyses from the Phase 3 PREVENT clinical trial evaluating SOLIRIS® (eculizumab) for the treatment of neuromyelitis optica spectrum disorder (NMOSD)

  March 5, 2020

   · 

  13 min read
• Pharm Country

  LifeSci Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering

  LifeSci Acquisition Corp. (NASDAQ: LSACU), a blank check company targeting the biopharma, medical technology, digital health and healthcare services sectors, announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit.

  March 5, 2020

   · 

  2 min read
• Deals

  Silk Road Medical Announces Uplisting to the Nasdaq Global Select Market® - March 05, 2020

  Silk Road Medical, Inc. announced that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol “SILK”.

  March 5, 2020

   · 

  1 min read